In another randomized control trial, enteral G-CSF administered to preterm infants was, similarly to EPO, associated with improved feeding tolerance and decreased incidence of NEC despite no increase in serum G-CSF levels [95]. The gene discussed is CSF3; the disease is necrotizing enterocolitis.